218 related articles for article (PubMed ID: 38549156)
1. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract][Full Text] [Related]
2. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
[TBL] [Abstract][Full Text] [Related]
5. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
Front Immunol; 2022; 13():983636. PubMed ID: 36159794
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
7. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
8. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
10. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion.
Zhang J; Li Y; Dai W; Tang F; Wang L; Wang Z; Li S; Ji Q; Zhang J; Liao Z; Yu J; Xu Y; Gong J; Hu J; Li J; Guo X; He F; Han L; Gong Y; Ouyang W; Wang Z; Xie C
Cancer Immunol Immunother; 2024 Mar; 73(4):71. PubMed ID: 38430394
[TBL] [Abstract][Full Text] [Related]
12. Integrated multi-omics characterization of KRAS mutant colorectal cancer.
Chong W; Zhu X; Ren H; Ye C; Xu K; Wang Z; Jia S; Shang L; Li L; Chen H
Theranostics; 2022; 12(11):5138-5154. PubMed ID: 35836817
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
14. Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer.
Sun Y; Liu B; Chen Y; Xing Y; Zhang Y
Front Cell Dev Biol; 2021; 9():811957. PubMed ID: 35223868
[No Abstract] [Full Text] [Related]
15. An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer.
Pei J; Gao Y; Wu A
Front Immunol; 2024; 15():1369726. PubMed ID: 38742117
[TBL] [Abstract][Full Text] [Related]
16. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
Zhang S; Fan W; He D
J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
[TBL] [Abstract][Full Text] [Related]
17. Cross-Talk Between m
Song W; Ren J; Xiang R; Yuan W; Fu T
Front Immunol; 2022; 13():740960. PubMed ID: 35350786
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer.
Su Y; Wang F; Lei Z; Li J; Ma M; Yan Y; Zhang W; Chen X; Xu B; Hu T
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203311
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of oxidative stress-related genes in colorectal cancer and its correlation with tumor immunity.
Yang L; Fang C; Zhang R; Zhou S
BMC Genomics; 2024 Jan; 25(1):8. PubMed ID: 38166604
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]